TransThera Biosciences Funding: $35M Raised, Series A (2016)
TransThera Biosciences is based in Nanjing, China. It has raised $35M in total funding. Latest round: Series A. Backed by Morningside Ventures.
TransThera Biosciences funding overview
TransThera Biosciences is based in Nanjing, China. TransThera Biosciences has raised $35M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2016. The round record for TransThera Biosciences runs through 2016; nothing later has been disclosed. Investors on record include Morningside Ventures.
TransThera Biosciences at a glance
Total raised
$35M
Latest round
Series A
Latest round date
October 2016
Headquarters
Nanjing, China
Notable investors
Morningside Ventures
Frequently asked about TransThera Biosciences funding
How much has TransThera Biosciences raised?
TransThera Biosciences has raised $35M in total disclosed funding across the rounds on record.
Who has invested in TransThera Biosciences?
Morningside Ventures are named among the investors backing TransThera Biosciences.
What was the latest TransThera Biosciences funding round?
The most recent disclosed round is a Series A, announced in October 2016.
Where is TransThera Biosciences based?
TransThera Biosciences is based in Nanjing, China.
When did TransThera Biosciences last raise?
The last disclosed TransThera Biosciences round closed in October 2016 at Series A.
Totals shown for TransThera Biosciences aggregate every disclosed round on file. To see how that compares, browse the companies in Nanjing and the investors behind them below.
